Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2001 | 12-2000 | 10-2000 | 05-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -3,998 | N/A | N/A |
| Depreciation Amortization | 3,130 | 3,130 | 5,114 | 2,700 | 2,700 |
| Accounts receivable | N/A | N/A | -5,271 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 3,952 | N/A | N/A |
| Other Working Capital | -8,860 | -8,860 | 554 | -2,180 | -2,180 |
| Other Operating Activity | 480 | 480 | 4,060 | 0 | 0 |
| Operating Cash Flow | $-5,250 | $-5,250 | $4,411 | $520 | $520 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,650 | -4,650 | -3,787 | -1,720 | -1,720 |
| Net Acquisitions | 0 | 0 | -6,793 | -5,810 | -5,810 |
| Other Investing Activity | 0 | 0 | -3,777 | 0 | 0 |
| Investing Cash Flow | $-4,650 | $-4,650 | $-14,357 | $-7,530 | $-7,530 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 18,944 | N/A | N/A |
| Debt Repayment | N/A | N/A | -2,172 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 707 | N/A | N/A |
| Other Financing Activity | -1,540 | -1,540 | -1,296 | 8,810 | 8,810 |
| Financing Cash Flow | $-1,540 | $-1,540 | $16,183 | $8,810 | $8,810 |
| Beginning Cash Position | N/A | N/A | 2,399 | N/A | N/A |
| End Cash Position | N/A | N/A | 8,636 | N/A | N/A |
| Net Cash Flow | $-11,440 | $-11,440 | $6,237 | $1,800 | $1,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,250 | -5,250 | 4,411 | 520 | 520 |
| Capital Expenditure | N/A | N/A | -3,787 | N/A | N/A |
| Free Cash Flow | -5,250 | -5,250 | 624 | 520 | 520 |